China National Accord Medicines Co. Ltd.

Pharmaceuticals
China
Earnings Per Share Growth (%)10.53%
Cost of Goods Sold (US$ Millions)$3,691
Current Liabilities (US$ Millions)$1,128
Total Assets (US$ Millions)$1,726
Long Term Debt$11
Return on Equity15.98%
Revenue (US$ Millions)$4,002
Total Company Assets$2,035
Revenue Growth (%)8.51%
Net Income (US$ Millions)$117
Earnings Per Share (US$)$10.53
Total Equity (US$ Millions)$840
Profit Margin (%)2.93%
Debt To Equity Ratio (%)0.01%
Inventory Turnover$390